The DOI matches its OpenAlex record; 53 of the 53 references it cites were found in a registry or an index.
Imatinib mesylate inhibits the profibrogenic activity of TGF-β and prevents bleomycin-mediated lung fibrosis
Open accessAbstract
Idiopathic pulmonary fibrosis is a progressive and fatal fibrotic disease of the lungs with unclear etiology. Prior efforts to treat idiopathic pulmonary fibrosis that focused on anti-inflammatory therapy have not proven to be effective. Recent insight suggests that the pathogenesis is mediated through foci of dysregulated fibroblasts driven by profibrotic cytokine signaling. TGF-beta and PDGF are 2 of the most potent of these cytokines. In the current study, we investigated the role of TGF-beta-induced fibrosis mediated by activation of the Abelson (Abl) tyrosine kinase. Our data indicate that fibroblasts respond to TGF-beta by stimulating c-Abl kinase activity independently of Smad2/3 phosphorylation or PDGFR activation. Moreover, inhibition of c-Abl by imatinib prevented TGF-beta-induced ECM gene expression, morphologic transformation, and cell proliferation independently of any effect on Smad signaling. Further, using a mouse model of bleomycin-induced pulmonary fibrosis, we found a significant inhibition of lung fibrosis by imatinib. Thus, Abl family members represent common targets for the modulation of profibrotic cytokine signaling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Transforming Growth Factor β in Tissue Fibrosis
Epstein, F. H., Border, W. A., & Noble, N. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311907 · Cited by 3,069
Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment: International Consensus Statement
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.ats3-00 · Cited by 2,628
Role of Transforming Growth Factor β in Human Disease
Blobe, G. C., Schiemann, W. P., & Lodish, H. F. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421807 · Cited by 2,427
Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J. D., Dalton, S. L., Wu, J., Pittet, J.-F., Kaminski, N., Garat, C., Matthay, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80545-0 · Cited by 2,076
Selman, M., King, T. E., & Pardo, A. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-2-200101160-00015 · Cited by 1,786
Sime, P. J., Xing, Z., Graham, F. L., Csaky, K. G., & Gauldie, J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119590 · Cited by 1,050
Prognostic Significance of Histopathologic Subsets in Idiopathic Pulmonary Fibrosis
BJORAKER, J. A., RYU, J. H., EDWIN, M. K., MYERS, J. L., TAZELAAR, H. D., SCHROEDER, D. R., & OFFORD, K. P. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.1.9704130 · Cited by 1,039
Kaartinen, V., Voncken, J. W., Shuler, C., Warburton, D., Bu, D., Heisterkamp, N., & Groffen, J. (1995) · Nature Genetics · doi:10.1038/ng1295-415 · Cited by 1,031
The epidemiology of interstitial lung diseases.
Coultas, D. B., Zumwalt, R. E., Black, W. C., & Sobonya, R. E. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.150.4.7921471 · Cited by 946
international consensus statement
Clements, R. V., & Simanowitz, A. (2000) · Cited by 852
Imatinib Mesylate — A New Oral Targeted Therapy
Savage, D. G., & Antman, K. H. (2002) · New England Journal of Medicine · doi:10.1056/nejmra013339 · Cited by 844
Broekelmann, T. J., Limper, A. H., Colby, T. V., & McDonald, J. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.15.6642 · Cited by 794
Self-citationOft, M., Peli, J., Rudaz, C., Schwarz, H., Beug, H., & Reichmann, E. (1996) · Genes & Development · doi:10.1101/gad.10.19.2462 · Cited by 681
Hocevar, B. A. (1999) · The EMBO Journal · doi:10.1093/emboj/18.5.1345 · Cited by 675
Branton, M. H., & Kopp, J. B. (1999) · Microbes and Infection · doi:10.1016/s1286-4579(99)00250-6 · Cited by 603
Interdependent SMAD and JNK Signaling in Transforming Growth Factor-β-mediated Transcription
Engel, M. E., McDonnell, M. A., Law, B. K., & Moses, H. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.52.37413 · Cited by 531
Leof, E. B., Proper, J. A., Goustin, A. S., Shipley, G. D., DiCorleto, P. E., & Moses, H. L. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.8.2453 · Cited by 529
Self-citationThe pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
Adamson, I. Y. R., & Bowden, D. H. (1974) · PubMed Central · Cited by 479
Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia.
Cohen, M. H., Williams, G., Johnson, J. R., Duan, J. Z., Gobburu, J. V. S., Rahman, A., Benson, K. A., Leighton, J. K., Kim, S. K., Wood, R., et al. (2002) · PubMed · Cited by 462
Plattner, R., Kadlec, L., DeMali, K. A., Kazlauskas, A., & Pendergast, A. M. (1999) · Genes & Development · doi:10.1101/gad.13.18.2400 · Cited by 427
Van Etten, R. A., Jackson, P., & Baltimore, D. (1989) · Cell · doi:10.1016/0092-8674(89)90102-5 · Cited by 413
Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice
Nakao, A., Fujii, M., Matsumura, R., Kumano, K., Saito, Y., Miyazono, K., & Iwamoto, I. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6094 · Cited by 405
TGF-β1-mediated fibroblast–myofibroblast terminal differentiation—the role of smad proteins
Evans, R. A., Tian, Y. A. C., Steadman, R., & Phillips, A. O. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(02)00015-0 · Cited by 398
Essential Roles for the Abl and Arg Tyrosine Kinases in Neurulation
Koleske, A. J., Gifford, A. M., Scott, M. L., Nee, M., Bronson, R. T., Miczek, K. A., & Baltimore, D. (1998) · Neuron · doi:10.1016/s0896-6273(00)80646-7 · Cited by 397
Fibrosis of the Lung and Other Tissues: New Concepts in Pathogenesis and Treatment
Sime, P. J., & O'Reilly, K. M. A. (2001) · Clinical Immunology · doi:10.1006/clim.2001.5008 · Cited by 330
Smad3 Mediates Transforming Growth Factor-β–Induced α-Smooth Muscle Actin Expression
Hu, B., Wu, Z., & Phan, S. H. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2003-0063oc · Cited by 325
Cycling, stressed-out and nervous: cellular functions of c-Abl
Van Etten, R. A. (1999) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01549-4 · Cited by 321
Nicholson, A. G., Fulford, L. G., Colby, T. V., du Bois, R. M., Hansell, D. M., & Wells, A. U. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2109039 · Cited by 299
The Abl family kinases: Mechanisms of regulation and signaling
(2002) · Advances in Cancer Research · doi:10.1016/s0065-230x(02)85003-5 · Cited by 296
Baarends, W. M., Helmond, M. J. L. V., Post, M., Schoot, P. J. C. M. V. D., Hoogerbrugge, J. W., Winter, J. P. D., Uilenbroek, J. T. J., Karels, B., Wilming, L. G., Meijers, J. H. C., et al. (1994) · Development · doi:10.1242/dev.120.1.189 · Cited by 290
Johansson, N., Ala-aho, R., Uitto, V.-J., Grénman, R., Fusenig, N. E., López-OtÍn, C., & Kähäri, V.-M. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.2.227 · Cited by 243
Role of Cytokines and Cytokine Therapy in Wound Healing and Fibrotic Diseases
Gharee-Kermani, M., & Pham, S. (2001) · Current Pharmaceutical Design · doi:10.2174/1381612013397573 · Cited by 192
Transient Transgene Expression of Decorin in the Lung Reduces the Fibrotic Response to Bleomycin
KOLB, M., MARGETTS, P. J., GALT, T., SIME, P. J., XING, Z., SCHMIDT, M., & GAULDIE, J. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.3.2006084 · Cited by 189
End points in cancer clinical trials and the drug approval process.
Schilsky, R. L. (2002) · PubMed · Cited by 170
Penheiter, S. G., Mitchell, H., Garamszegi, N., Edens, M., Doré, J. J. E., & Leof, E. B. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.13.4750-4759.2002 · Cited by 167
Self-citationWoodring, P. J., Litwack, E. D., O'Leary, D. D. M., Lucero, G. R., Wang, J. Y. J., & Hunter, T. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200110014 · Cited by 165
Rice, A. B., Moomaw, C. R., Morgan, D. L., & Bonner, J. C. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65115-2 · Cited by 158
Chronic liver injury, TGF-β, and cancer
Bissell, D. M. (2001) · Experimental & Molecular Medicine · doi:10.1038/emm.2001.31 · Cited by 153
Interstitial Fibrosis and Growth Factors
Lasky, J. A., & Brody, A. R. (2000) · Environmental Health Perspectives · doi:10.1289/ehp.00108s4751 · Cited by 153
Idiopathic pulmonary fibrosis: new insights in its pathogenesis
Pardo, A., & Selman, M. (2002) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00091-2 · Cited by 140
Cell-Type-Specific Activation of PAK2 by Transforming Growth Factor β Independent of Smad2 and Smad3
Wilkes, M. C., Murphy, S. J., Garamszegi, N., & Leof, E. B. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.23.8878-8889.2003 · Cited by 139
Self-citationPlatelet-derived growth factor plays a key role in proliferative vitreoretinopathy.
Andrews, A., Balciunaite, E., Leong, F. L., Tallquist, M. D., Soriano, P. M., Refojo, M. F., & Kazlauskas, A. (1999) · PubMed · Cited by 132
Butt, R. P., Laurent, G. J., & Bishop, J. E. (1995) · PubMed · Cited by 114
The Extracellular Matrix Dynamically Regulates Smooth Muscle Cell Responsiveness to PDGFa
Raines, E. W., Koyama, H., & Carragher, N. O. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06299.x · Cited by 95
Christensen, P. J., Goodman, R. E., Pastoriza, L., Moore, B. B., & Toews, G. B. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65493-4 · Cited by 87
Sachdev, P., Zeng, L., & Wang, L. H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111575200 · Cited by 84
The BCR/ABL oncogene alters the chemotactic response to stromal-derived factor-1alpha.
Salgia, R., Quackenbush, E. J., Lin, J. J., Souchkova, N., Sattler, M., Ewaniuk, D. S., Klucher, K. M., Daley, G. Q., Kraeft, S. K., Sackstein, R., et al. (1999) · PubMed · doi:10.1182/blood.v94.12.4233 · Cited by 82
Kadlec, L., & Pendergast, A. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12390 · Cited by 58
Augmentation of fibroblast proliferation by bleomycin.
Moseley, P. L., Hemken, C., & Hunninghake, G. W. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112695 · Cited by 58
Mechanisms of Pulmonary Fibrosis
Strieter, R. M. (2001) · CHEST Journal · doi:10.1378/chest.120.1_suppl.s77-a · Cited by 52
Tran, P.-L., Weinbach, J., Opolon, P., Linares‐Cruz, G., Reynes, J.-P., Grégoire, A., Kremer, E. J., Durand, H., & Perricaudet, M. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119203 · Cited by 48
Kim, J.-T., & Joo, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201178200 · Cited by 38
Interstitial Fibrosis and Growth Factors
Lasky, J. A., & Brody, A. R. (2000) · Environmental Health Perspectives · doi:10.2307/3454412 · Cited by 29
Research works printed but not linked: 8
- Cohen, 2002, Clin. Cancer Res., 8, 935
- Salgia, 1999, Blood., 94, 4233
- Andrews, 1999, Invest. Ophthalmol. Vis. Sci., 40, 2683
- 10.1074/jbc.M000711200 · doi:10.1074/jbc.m000711200
- Hu, 2003, Am. J. Respir. Crit. Care Med., 29, 397
- Butt, 1995, Eur. J. Cell Biol., 68, 330
- Adamson, 1974, Am. J. Pathol., 77, 185
- Cutroneo, 1986, Chest., 89(3 Suppl.), 121S, 10.1378/chest.89.3_Supplement.121S · doi:10.1378/chest.89.3_supplement.121s
Cited by
Cellular and molecular mechanisms of fibrosis
Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495
Non-Smad pathways in TGF-β signaling
Zhang, Y. E. (2009) · Cell Research · doi:10.1038/cr.2008.328 · Cited by 1,749
Transforming growth factor–β in tissue fibrosis
Frangogiannis, N. G. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20190103 · Cited by 1,278
Systemic sclerosis: a prototypic multisystem fibrotic disorder
Varga, J., & Abraham, D. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31139 · Cited by 1,163
Biernacka, A., Dobaczewski, M., & Frangogiannis, N. G. (2011) · Growth Factors · doi:10.3109/08977194.2011.595714 · Cited by 1,161
Metadata
- Authors
- Daniels, C. E., Wilkes, M. C., Edens, M., Kottom, T. J., Murphy, S. J., LIMPER, A. H., & Leof, E. B.
- Venue
- Journal of Clinical Investigation
- Published
- 2004-11-01
- Volume
- 114
- Issue
- 9
- Pages
- 1308-1316
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1977445008
- Cited by
- 574
- References
- 53
- FWCI
- 23.42
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.